Literature DB >> 20638348

Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease duration.

José M Miralles-García1, Pedro de Pablos-Velasco, Lucio Cabrerizo, María Pérez, Vanessa López-Gómez.   

Abstract

OBJECTIVES: Results of studies on the prevalence of distal diabetic polyneuropathy (DPN) are contradictory. Conventional methods used for the diagnosis of DPN in clinical practice have limited effectiveness. The present study aimed to assess the prevalence of DPN in a population with long-standing diabetes (more than 10 years disease duration) by measuring vibratory, thermal and tactile sensitivities with quantitative sensory devices, as well as their relationship with associated clinical risk factors. PATIENTS AND METHODS: A total of 1011 diabetic patients were evaluated in a multicenter, cross-sectional, observational study. The three sensitivities were assessed by ultrabiothesiometer, aesthesiometer and thermoskin devices, respectively. The prevalence of neuropathic pain was validated by the DN4 questionnaire.
RESULTS: Of the 1011 cases included, 400 (39.6%) met the diagnostic criteria of DPN, while no DPN was found in the remaining 611 (60.4%). Of the 400 patients with DPN, 253 (63.2%) showed clinical manifestations, while 147 (36.8%) were diagnosed as subclinical DPN. The prevalence of DPN increased with disease duration. There was a progressive loss of the three sensitivities with increased disease duration, particularly thermal and vibratory sensitivities. This loss was statistically significant for the latter two sensitivities. Among patients with clinical DPN, 84.2% had painful neuropathic symptoms. The prevalence of DPN was positively related to micro- and macroangiopathic complications and with dyslipidemia.
CONCLUSION: This study reveals a high degree of underdiagnosis of DPN, most likely due to the asymptomatic nature of the disease in a considerable proportion of patients. Our observations provide evidence of the usefulness of specific equipment for quantitative and objective assessment of polyneuropathy.
Copyright © 2010 SEEN. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20638348     DOI: 10.1016/j.endonu.2010.05.006

Source DB:  PubMed          Journal:  Endocrinol Nutr        ISSN: 1575-0922


  14 in total

Review 1.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

2.  Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity.

Authors:  Birtha Hansen; Søren K Lilleøre; Gitte Ter-Borch
Journal:  Diabetes Technol Ther       Date:  2011-03-15       Impact factor: 6.118

3.  Comparison of clinically relevant technical attributes of five insulin injection pens.

Authors:  Toshinari Asakura
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

Review 4.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Prevalence and associated factors of painful diabetic peripheral neuropathy among diabetic patients on follow up at Jimma University Medical Center.

Authors:  Daba Abdissa
Journal:  J Diabetes Metab Disord       Date:  2020-10-15

6.  Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients.

Authors:  Nermin Tanik; Serhat Tanik; Sebahattin Albayrak; Kürsat Zengin; Levent Ertugrul Inan; Emel Kiyak Caglayan; Asuman Celikbilek; Kadir Kirboga; Mesut Gurdal
Journal:  Int Neurourol J       Date:  2016-09-23       Impact factor: 2.835

7.  Comparison of efficiencies of michigan neuropathy screening instrument, neurothesiometer, and electromyography for diagnosis of diabetic neuropathy.

Authors:  Turkan Mete; Yusuf Aydin; Mustafa Saka; Halise Cinar Yavuz; Sule Bilen; Yavuz Yalcin; Berna Arli; Dilek Berker; Serdar Guler
Journal:  Int J Endocrinol       Date:  2013-05-22       Impact factor: 3.257

8.  Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety).

Authors:  Javad Kiani; Saman Ahmad Nasrollahi; Farzaneh Esna-Ashari; Puyan Fallah; Firuzeh Sajedi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  Lower leg muscle strengthening does not redistribute plantar load in diabetic polyneuropathy: a randomised controlled trial.

Authors:  Tom Melai; Nicolaas C Schaper; T Herman Ijzerman; Ton Lh de Lange; Paul Jb Willems; Valéria Lima Passos; Aloysius G Lieverse; Kenneth Meijer; Hans Hcm Savelberg
Journal:  J Foot Ankle Res       Date:  2013-10-18       Impact factor: 2.303

10.  Risk factors for neuropathic pain in diabetes mellitus.

Authors:  Harry L Hébert; Abirami Veluchamy; Nicola Torrance; Blair H Smith
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.